Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07286994 Gamification and Physical Activity in PD |
Gamification and Physical Activit… | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | VA Office of Research and Develop… | United States · Corporal Michael J. Crescenz VA Medic… | 2026-10-01 → 2030-09-30 | Ouvrir |
| NCT04624204 Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pem… |
Pembrolizumab 200 mg | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Belgium, Bulgaria, Canada, … | 2020-12-08 → 2027-10-28 | Ouvrir |
| NCT06638944 Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke … |
Wearable Biofeedback for Swallowi… | Parkinson | Phase 2 | RECRUITING | En attente / non publié | University of Illinois at Urbana-… | United States · Purdue University, West Lafayette, Un… | 2025-07-22 → 2029-04-30 | Ouvrir |
| NCT05931575 Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fas… |
Fasudil hydrochloride | Parkinson | Phase 2 | COMPLETED | En attente / non publié | Technical University of Munich | Germany · Technische Universität München, Klinikum re… | 2023-09-11 → 2026-08-24 | Ouvrir |
| NCT07804615 Vista PD — A Study to Evaluate the Efficacy, PK, Safety, and Tolerabili… |
VIM0423 | Parkinson | Phase 2 | RECRUITING | En attente / non publié | Vima Therapeutics | United States, Canada · Vima Site #002, Farmington Hi… | 2026-09 → 2027-06 | Ouvrir |
| NCT07815964 Turkish Validity and Reliability of the Parkinson's Disease Neuropsycho… |
Turkish Validity and Reliability … | Parkinson | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Acibadem University | Turkey (Türkiye) · Acibadem University, Istanbul, Tur… | 2026-10-01 → 2027-07-01 | Ouvrir |
| NCT03100149 PASADENA — A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/… |
RO7046015 | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Austria, France, Germany, Spain · Asso… | 2017-06-27 → 2031-12-01 | Ouvrir |
| NCT06920511 OPERA — Cognitive Rehabilitation With Virtual Reality in Parkinson Dise… |
Cognitve rehabilitation with virt… | Parkinson | Non applicable | COMPLETED | En attente / non publié | Fondazione Don Carlo Gnocchi ETS | Italy · Fondazione Don Gnocchi, Sant'Angelo dei Lomba… | 2025-05-01 → 2025-10-31 | Ouvrir |
| NCT07814534 Synthetic Vasomotion for Glymphatic Enhancement |
Active noninvasive vagus nerve st… | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Florida Institute for Human and M… | Non communiqué | 2026-09 → 2026-11 | Ouvrir |
| NCT03010826 Pharmacological Recruitment of Endogenous Neural Precursors to Promote … |
Pharmacological Recruitment of En… | SEP | À vérifier | COMPLETED | En attente / non publié | The Hospital for Sick Children | Canada · Hospital for Sick Children, Toronto, Canada … | 2016-12 → 2018-11-16 | Ouvrir |
| NCT04495556 CAVS-MS — Central Vein Sign: a Diagnostic Biomarker in Multiple Scleros… |
CAVS-MS — Central Vein Sign: a Di… | SEP | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | The Cleveland Clinic | United States, Canada · Cedars-Sinai Medical Center, … | 2020-06-11 → 2027-01 | Ouvrir |
| NCT00000117 Intravenous Immunoglobulin Therapy in Optic Neuritis |
Immunoglobulin | SEP | Phase 3 | COMPLETED | En attente / non publié | National Eye Institute (NEI) | United States · Mayo Clinic, Department of Neurology,… | 1995-08 → 1997-12 | Ouvrir |
| NCT06171334 Remote Ischemic Conditioning in PPMS |
Remote ischemic conditioning | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Calgary | Canada · University of Calgary, Calgary, Canada | 2024-07-01 → 2026-12-01 | Ouvrir |
| NCT07483450 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmac… |
Ocrelizumab | SEP | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | China · 1st Affiliated Hospital of Shanxi Medical Uni… | 2025-07-04 → 2028-12-31 | Ouvrir |
| NCT03972306 A Study To Investigate The Pharmacokinetics, Safety, And Tolerability O… |
Ocrelizumab | SEP | Phase 1 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Cleveland Clinic Mellen Center, Cleve… | 2019-08-12 → 2025-06-03 | Ouvrir |
| NCT04261790 Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple… |
Ocrelizumab | SEP | Phase 4 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Johns Hopkins University, Baltimore, … | 2020-08-01 → 2024-11-01 | Ouvrir |
| NCT07181811 ML45855 — Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on… |
ML45855 — Assessing the Effects o… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Anza Memon | United States · John D. Dingell VA Medical Center, De… | 2025-09-30 → 2028-06-01 | Ouvrir |
| NCT04237337 PVSEPK — Drugs for the Treatment of Multiple Sclerosis and Risk of Canc… |
PVSEPK — Drugs for the Treatment … | SEP | À vérifier | UNKNOWN | En attente / non publié | University Hospital, Caen | Non communiqué | 2020-01 → 2020-03 | Ouvrir |
| NCT07804004 CRSP-AID-502 — A Safety and Efficacy Study Evaluating CTX112 in Subject… |
CTX112 | SEP | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | CRISPR Therapeutics | Non communiqué | 2026-09-15 → 2029-12-30 | Ouvrir |
| NCT06261489 Cannabis (THC vs. CBD) in Multiple Sclerosis |
THC | SEP | Phase 2 | RECRUITING | En attente / non publié | University of Calgary | Canada · University of Calgary Foothills Medical Cent… | 2025-12-05 → 2027-09-30 | Ouvrir |
| NCT04116424 VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Pat… |
VIGIP-SEP2: Training of Patients … | SEP | Non applicable | COMPLETED | En attente / non publié | University Hospital, Caen | France · Centre SEP Caen, Caen, France | 2020-12-01 → 2026-07-29 | Ouvrir |
| NCT07771868 High-Intensity Interval Training for Walking and Function Across Differ… |
High-Intensity Interval Training … | SEP | Non applicable | RECRUITING | En attente / non publié | Hacettepe University | Turkey (Türkiye) · Hatay Mustafa Kemal Universty, Hat… | 2026-09-01 → 2028-01-31 | Ouvrir |
| NCT06408259 Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to … |
Ozanimod | SEP | Phase 3 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Australia, Italy, Mexico, Poland, Port… | 2025-04-08 → 2036-07-13 | Ouvrir |
| NCT06219304 FAST — Effect of High Intensity Training on Motor and Cognitive Functio… |
FAST — Effect of High Intensity T… | SEP | Non applicable | COMPLETED | En attente / non publié | Fondazione Don Carlo Gnocchi ETS | Italy · Fondazione IRCCS Don Carlo Gnocchi, Milan, It… | 2023-09-01 → 2025-12-31 | Ouvrir |
| NCT07680049 The Mediating Role of Balance in the Relationship Between Fatigue and F… |
The Mediating Role of Balance in … | SEP | À vérifier | COMPLETED | En attente / non publié | Uskudar University | Turkey (Türkiye) · Uskudar University, Istanbul, Turk… | 2026-07-01 → 2026-09-01 | Ouvrir |